Sei sulla pagina 1di 2

DRUG STUDY

Patient's Initial: R.O.B Medical Diagnosis: Cerebrovascular Accident

Age: 46Y Category: 3


Gender: M Room No.: MW#16
Date Admitted: March 25, 2014 Student Nurse: Ledesma, Fatima Mae

Indication/ Contraindication Mechanism of Action Side Effects/ Adverse Effect Nursing Considerations

Generic Name: Indications: Atorvastatin competitively Adverse Effect:  Stress that atorvastatin is an
Atorvastatin  Reduction of risk of inhibits HMG-CoA reductase, Headache, flatulence, diarrhoea, adjunct to – not a substitute
stroke and heart attack in type the enzyme that catalyses the nausea, vomiting, anorexia, for low-cholesterol diet
Brand Name: 2 diabetes patients without conversion of HMG-CoA to xerostomia, angioedema,  Tell patient to take drug at the
lipitor evidence of heart disease but mevalonic acid. This results in myalgia, rash/pruritus, alopecia, same time each day to
with other CV risk factors, and the induction of the LDL allergy, infection, chest pain.  maintain its effects
Classification: revascularization procedures in receptors, leading to lowered  Instruct patient to take a
Dyslipidaemic Agent patients without evidence of LDL-cholesterol concentration. Potentially missed dose as soon as
coronary heart disease (CHD) Absorption: Rapid from the GI Fatal: Thrombocytopenia. possible. If it’s almost time
Dosage: but with multiple risk factors tract (oral). Rhabdomyolysis with acute for his next dose, he should
20mg other than diabetes (eg, Distribution: Protein-binding: renal failure. skip the missed dose.
smoking, HTN, low HDL-C, 98%.  Advise patient to notify
Frequency: family history of early CHD) Metabolism: Extensively prescriber immediately if he
Once daily 2000H  Patients with CHD, to hepatic; converted to active develops unexplained muscle
reduce risks of MI, inhibitors of HMG-CoA pain, tenderness, or weakness,
Route: revascularization procedures, reductase. especially if accompanied by
G-tube hospitalization for CHF, and Excretion: Faeces (as fatigue or fever
angina metabolites); 14 hr (elimination
Date ordered: half-life).
March 19, 2014 Contraindication:
Hypersensitivity, active liver
disease or unexplained persistent
elevations of serum
transaminase, porphyria,
pregnancy, lactation.

Potrebbero piacerti anche